26.21
0.85%
+0.22
Integra Lifesciences Holdings Corp Aktie (IART) Neueste Nachrichten
Integra LifeSciences to Present at the 2024 Bank of America Healthcare Conference
GlobeNewswire Inc.
Deciphering Integra (IART) International Revenue Trends
Zacks Investment Research
A Glimpse Into The Expert Outlook On Integra Lifesciences Through 8 Analysts
Benzinga
Integra's (IART) Q1 Earnings Match Estimates, Margins Down
Zacks Investment Research
Stocks On Track For Third Green Session, Palantir Ignites Rally In Chipmakers, Commodities Rebound: What's Driving Markets Monday?
Benzinga
Integra (IART) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks Investment Research
Integra LifeSciences Reports First Quarter 2024 Financial Results
GlobeNewswire Inc.
Integra LifeSciences to Spotlight CereLink® Intracranial Pressure (ICP) Monitoring System at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting
GlobeNewswire Inc.
Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024
GlobeNewswire Inc.
Edwards Lifesciences (EW) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zacks Investment Research
Earnings Preview: Integra LifeSciences (IART) Q1 Earnings Expected to Decline
Zacks Investment Research
Here's Why Investors Should Retain Integra (IART) Stock Now
Zacks Investment Research
Integra LifeSciences Completes the Acquisition of Acclarent, Inc.
GlobeNewswire Inc.
Why Is Integra (IART) Down 4% Since Last Earnings Report?
Zacks Investment Research
Integra LifeSciences (IART) Introduces MicroMatrix Flex
Zacks Investment Research
Integra LifeSciences Launches MicroMatrix® Flex to Provide Convenient Access to Hard-to-Reach Areas in Complex Cases
GlobeNewswire Inc.
Top 3 Health Care Stocks That Could Lead To Your Biggest Gains In March
Benzinga
Analyst Scoreboard: 5 Ratings For Integra Lifesciences
Benzinga
Integra's (IART) Q4 Earnings Miss Estimates, Margins Down
Zacks Investment Research
Compared to Estimates, Integra (IART) Q4 Earnings: A Look at Key Metrics
Zacks Investment Research
Integra LifeSciences (IART) Misses Q4 Earnings and Revenue Estimates
Zacks Investment Research
Integra LifeSciences Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides 2024 Financial Guidance
GlobeNewswire Inc.
Integra (IART) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
Zacks Investment Research
Earnings Preview: Integra LifeSciences (IART) Q4 Earnings Expected to Decline
Zacks Investment Research
Integra LifeSciences to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024
GlobeNewswire Inc.
Edwards Lifesciences (EW) Q4 Earnings Match Estimates
Zacks Investment Research
Thermo Fisher Scientific (TMO) Tops Q4 Earnings and Revenue Estimates
Zacks Investment Research
Here's Why Investors Should Retain Integra (IART) Stock Now
Zacks Investment Research
Integra LifeSciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
The Analyst Landscape: 7 Takes On Integra Lifesciences
Benzinga
Integra (IART) to Advance ENT Division With New Buyout Deal
Zacks Investment Research
Integra LifeSciences Announces Definitive Agreement to Acquire Acclarent®
GlobeNewswire Inc.
Integra LifeSciences Appoints Jeff Graves, Ph.D., to Board of Directors
GlobeNewswire Inc.
Integra Gains From New Product Launches, Mounting Costs Ail
Zacks Investment Research
The Latest Analyst Ratings for Integra Lifesciences
Benzinga
Block To Rally Around 54%? Here Are 10 Top Analyst Forecasts For Tuesday
Benzinga
Why Is Glaukos (GKOS) Down 0.4% Since Last Earnings Report?
Zacks Investment Research
Why Is Integra (IART) Up 10.2% Since Last Earnings Report?
Zacks Investment Research
4 Analysts Have This to Say About Integra Lifesciences
Benzinga
Kapitalisierung:
|
Volumen (24h):